In silico analysis reveals the anti-malarial potential of quinolinyl chalcone derivatives

被引:26
|
作者
Thillainayagam, Mahalakshmi [1 ]
Pandian, Lavanya [1 ]
Murugan, Kumar Kalavathy [1 ]
Vijayaparthasarathi, Vijayakumar [2 ]
Sundaramoorthy, Sarveswari [2 ]
Anbarasu, Anand [1 ,2 ]
Ramaiah, Sudha [1 ]
机构
[1] VIT Univ, Sch Biosci & Technol, Med & Biol Comp Lab, Vellore 632014, Tamil Nadu, India
[2] VIT Univ, Ctr Organ & Med Chem, Vellore 632014, Tamil Nadu, India
来源
关键词
molecular docking; anti-malarial compounds; quinolinyl chalcone derivatives; CoMFA; PARASITE PLASMODIUM-FALCIPARUM; PROTEIN-LIGAND INTERACTIONS; LACTATE-DEHYDROGENASE; MOLECULAR DOCKING; DRUG DISCOVERY; BINDING-SITE; 3D QSAR; INHIBITORS; 3D-QSAR; VITRO;
D O I
10.1080/07391102.2014.920277
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, the correlation between chemical structures and various parameters such as steric effects and electrostatic interactions to the inhibitory activities of quinolinyl chalcone derivatives is derived to identify the key structural elements required in the rational design of potent and novel anti-malarial compounds. The molecular docking simulations and Comparative Molecular Field Analysis (CoMFA) are carried out on 38 chalcones derivatives using Plasmodium falciparum lactate dehydrogenase (PfLDH) as potential target. Surflex-dock is used to determine the probable binding conformations of all the compounds at the active site of pfLDH and to identify the hydrogen bonding interactions which could be used to alter the inhibitory activities. The CoMFA model has provided statistically significant results with the cross-validated correlation coefficient (q(2)) of .850 and the non-cross-validated correlation coefficient (r(2)) of .912. Standard error of estimation (SEE) is .280 and the optimum number of component is five. The predictive ability of the resultant model is evaluated using a test set comprising of 13 molecules and the predicted r(2) value is .885. The results provide valuable insight for optimization of quinolinyl chalcone derivatives for better anti-malarial therapy.
引用
收藏
页码:961 / 977
页数:17
相关论文
共 50 条
  • [31] Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria
    Yeo, Seon-Ju
    Liu, Dong-Xu
    Kim, Hak Sung
    Park, Hyun
    MALARIA JOURNAL, 2017, 16
  • [32] Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii
    Mout, Rubul
    Xu, Zhi-Dong
    Wolf, Angela K. H.
    Davisson, Vincent Jo
    Jarori, Gotam K.
    MALARIA JOURNAL, 2012, 11
  • [33] Anti-malarial effect of novel chloroquine derivatives as agents for the treatment of malaria
    Seon-Ju Yeo
    Dong-Xu Liu
    Hak Sung Kim
    Hyun Park
    Malaria Journal, 16
  • [34] Synthesis and Biological Evaluation of Some Pyrazole Derivatives as Anti-Malarial Agents
    Bekhit, Adnan A.
    Hymete, Ariaya
    Asfaw, Henok
    Bekhit, Alaa El-Din A.
    ARCHIV DER PHARMAZIE, 2012, 345 (02) : 147 - 154
  • [35] Place of Artemisinin derivatives as anti-malarial drugs in paediatric hospitalization in Abidjan
    Abrogoua, Danho Pascal
    Kablan, Brou Jerome
    Ahipo, Babo Gilles
    THERAPIE, 2007, 62 (02): : 151 - 161
  • [36] Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents
    Chaturvedi, Devdutt
    Goswami, Abhishek
    Saikia, Partha Pratim
    Barua, Nabin C.
    Rao, Paruchuri G.
    CHEMICAL SOCIETY REVIEWS, 2010, 39 (02) : 435 - 454
  • [37] Hemisynthesis of Pentacyclic Triterpenoids from Diospyros foxworthyi with In vitro and In silico Anti-malarial Evaluation
    Ghani, Muhammad Solehin Abd
    Abu Bakar, Nur Ain Latifhaa
    Ramadani, Arba Pramundita
    Nugraha, Arde Toga
    Awang, Khalijah Binti
    Omar, Mohammad Tasyriq Che
    Supratman, Unang
    Kamarulzaman, Ezatul Ezleen
    Taib, Mohamad Nurul Azmi Mohamad
    CURRENT ORGANIC CHEMISTRY, 2024, 28 (10) : 799 - 814
  • [38] In Silico and In Vivo Anti-Malarial Studies of 18β Glycyrrhetinic Acid from Glycyrrhiza glabra
    Kalani, Komal
    Agarwal, Jyoti
    Alam, Sarfaraz
    Khan, Feroz
    Pal, Anirban
    Srivastava, Santosh Kumar
    PLOS ONE, 2013, 8 (09):
  • [39] Exploring potential of Plasmodium RUVBL proteins as anti-malarial drug target
    Khurana, Juhi
    Shrivastava, Ashish
    Singh, Ashutosh
    Gupta, Ashish
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (02): : 736 - 752
  • [40] Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication
    Rongjuan Dai
    Xinqiang Xiao
    Feng Peng
    Mingming Li
    Guozhong Gong
    Virus Genes, 2016, 52 : 22 - 28